根据《深圳证券交易所股票上市规则》、《企业会计准则》以及威海华东数 控股份有限公司（以下简称"公司"）审计委员会有关规定，公司董事会审计委员 会对公司计提资产减值准备相关材料进行了审查，基于审慎的判断，对公司计提 资产减值准备作出如下说明： 公司本次计提资产减值准备遵照并符合《企业会计准则》和公司相关会计政 策的规定，本次计提资产减值准备基于谨慎性原则，依据充分，符合公司资产现 状，有助于更加公允地反映截止 2023 年 6 月 30 日公司的财务状况、资产价值及 经营成果，使公司关于资产价值的会计信息更加真实可靠，更具合理性。 关于计提资产减值准备的合理性说明 威海华东数控股份有限公司董事会审计委员会 二〇二三年八月十八日 威海华东数控股份有限公司审计委员会 ...

证券代码：002248 证券简称：华东数控 公告编号：2023-013 威海华东数控股份有限公司 关于2023年半年度计提资产减值准备的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 2、本次计提资产减值准备的资产范围和金额 本次计提资产减值准备的资产范围为：华东数控及合并报表范围内的子公司 威海华东数控机床有限公司、上海原创精密机床主轴有限公司的应收款项、存货 及在建工程。 本次计提资产减值准备的预计金额为：报告期内公司合并报表范围内的应收 款项计提坏账准备 129.46 万元，存货计提减值准备 116.53 万元，在建工程计提 1 减值准备 34.28 万元，总计计提减值准备 280.27 万元，占公司最近一个会计年 度（2022 年度）经审计净利润的 24.03%。公司 2022 年度归属于上市公司股东 的净利润为 1,166.17 万元。 公司本次计提的资产减值准备计入 2023 年半年度。 威海华东数控股份有限公司（简称"公司"、"华东数控"）根据《深圳证券交 易所股票上市规则》中关于计提资产减值准备的规定，本着谨慎性原则，对合并 财务报表范围 ...

编号：2023-001 | 投资者关系活动类别 | □特定对象调研 □分析师会议 | | --- | --- | | | □媒体采访 ☑业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他（请文字说明其他活动内容） | | | 通过全景网"投资者关系互动平台"（http://ir.p5w.net）"网 | | 参与单位名称及人员 姓名 | 络远程参与公司 年年度报告网上说明会的广大投资 2022 | | | 者 | | 时间 | 2023 年 5 月 10 日 15:00-17:00 | | 地点 | 全景网"投资者关系互动平台"（http://ir.p5w.net） | | 上市公司接待人员 | 董事长连小明、董事会秘书刘璐、财务总监肖崔英、独立 | | | 董事姜爱丽 | | | 1、请问公司对下一步发展有什么规划？ | | | 答：您好！公司 2023 年度经营方针为凝心聚力、行稳致 | | | 远、开创未来，主要在市场、生产等四个方面采取措施提 | | | 升管理水平，具体可参见刊载于巨潮资讯网的《2022 年 | | | 年度报告》第三节管理层讨论与分析十一、 ...

Financial Performance - The company reported a significant increase in revenue for 2022, reaching RMB 1.2 billion, representing a year-over-year growth of 15%[18]. - The company's operating revenue for 2022 was ¥254,462,854.25, a decrease of 19.24% compared to ¥315,080,796.62 in 2021[24]. - The net profit attributable to shareholders for 2022 was ¥11,661,723.14, down 17.83% from ¥14,192,053.45 in 2021[24]. - The net profit after deducting non-recurring gains and losses was ¥5,037,526.34, a decline of 30.29% from ¥7,225,949.46 in 2021[24]. - The net cash flow from operating activities was negative at -¥14,779,617.61, a significant decrease of 163.87% compared to ¥23,138,353.37 in 2021[24]. - The company achieved operating revenue of CNY 254.46 million, a year-on-year decrease of 19.24%[41]. - The net profit attributable to shareholders was CNY 11.66 million, down 17.83% year-on-year[41]. - The company reported a net cash flow from operating activities of -¥14.78 million, a decrease of 163.87% year-on-year[54]. - The company reported a significant increase in user data, with a notable growth in customer engagement metrics compared to the previous year[112]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion RMB, representing a year-over-year growth of 15%[116]. Market Expansion and Strategy - The company plans to expand its market presence in Southeast Asia, targeting a 15% market share within the next two years[18]. - The company has set ambitious targets for 2023, aiming for a revenue growth of 10% to reach RMB 1.32 billion, contingent on market conditions[6]. - Market expansion plans include entering two new international markets by the end of Q3 2023, aiming to increase market share by 20%[115]. - The company is expanding its market presence, targeting an increase in market share by 5% in the next year[116]. - The company aims to enhance market channels and team building, focusing on industries with high growth potential such as 5G, engineering machinery, aerospace, and new energy vehicles[88]. Research and Development - The company has allocated RMB 100 million for research and development in 2023, focusing on automation technologies[18]. - The company holds 171 patents, including 32 invention patents and 136 utility model patents, showcasing its strong R&D capabilities[44]. - The company is investing heavily in R&D, with a budget allocation of approximately 10 million yuan for the development of new technologies in the upcoming year[114]. - Research and development investments have increased by 25%, focusing on advanced medical equipment and diagnostics[116]. - The company has completed the prototype of the XHW2350*140 CNC gantry machining center, aiming for a production capacity of 15 units per year, targeting the aerospace and automotive mold manufacturing sectors[67]. Operational Efficiency and Cost Management - The management emphasizes the importance of adapting to market changes and enhancing operational efficiencies to mitigate risks[6]. - The management team has outlined a cost-reduction strategy aimed at decreasing operational expenses by 8% over the next year[114]. - The company reported a significant reduction in operational costs by 5% through efficiency improvements in production[118]. - The company aims to enhance operational efficiency, targeting a reduction in costs by 8% through process optimization[116]. Risks and Challenges - The company faces potential risks in the upcoming year, including supply chain disruptions and fluctuating raw material costs, which could impact profitability[6]. - The company faces risks from macroeconomic fluctuations and market competition, particularly in the CNC machine tool sector, where competition is intense both domestically and internationally[91]. - The company has implemented measures to manage raw material price volatility, particularly for castings, which are a significant cost component[91]. - The company faces technical development risks due to increasing customer demands for customized products, which may hinder production technology preparation[92]. Governance and Management - The company has established a sound internal control system and governance structure, enhancing the protection of investor interests[98]. - The board of directors consists of eight members, including three independent directors, ensuring compliance with governance standards[99]. - The company has maintained a stable management team with no significant changes in the board of directors during the reporting period[109]. - The company has committed to avoiding any business that competes with Huadong CNC and its subsidiaries, ensuring no conflict of interest exists[158]. Shareholder and Investor Relations - No cash dividends or stock bonuses will be distributed to shareholders for the fiscal year 2022, as the company aims to reinvest profits into growth initiatives[7]. - The board has approved a dividend payout of 0.5 yuan per share, reflecting a commitment to returning value to shareholders while maintaining growth initiatives[112]. - The profit distribution policy emphasizes reasonable returns to investors, with a minimum cash dividend of 10% of the distributable profit for the year[134]. Product Development and Offerings - New product development includes the launch of a next-generation CNC machine, expected to enhance operational efficiency by 25%[18]. - The company continues to focus on advanced technology integration in its products, ensuring high rigidity and energy efficiency[38]. - The company introduced two new product lines, which are anticipated to contribute an additional 200 million RMB in revenue next year[117]. Employee and Workforce Management - The total number of employees at the end of the reporting period is 341, with 299 from the parent company and 38 from major subsidiaries[130]. - The company has established a competitive salary system based on industry standards, combining basic salary and performance-based incentives for different employee categories[131]. - The professional composition includes 198 production personnel, 46 sales personnel, 41 technical personnel, 7 financial personnel, and 49 administrative personnel[130].

Financial Performance - The company's operating revenue for Q1 2023 was ¥70,118,725.26, representing a 16.21% increase compared to ¥60,338,203.65 in the same period last year[3] - Net profit attributable to shareholders was ¥4,752,436.05, up 16.00% from ¥4,097,049.65 year-on-year[3] - The net profit after deducting non-recurring gains and losses increased by 36.11% to ¥3,764,465.92 from ¥2,765,811.12 in the previous year[3] - Basic and diluted earnings per share both doubled to ¥0.02 from ¥0.01 year-on-year[3] - Operating profit for the current period was ¥4,553,614.14, up from ¥4,006,920.87, reflecting a growth of 13.7%[17] - The company’s total profit for the current period was ¥4,684,092.38, an increase from ¥4,019,397.15 in the previous period, showing overall growth[17] Cash Flow - The net cash flow from operating activities improved significantly to ¥8,633,841.76, a 271.32% increase from a negative cash flow of -¥5,039,453.40 in the same period last year[3] - Cash and cash equivalents at the end of the period were ¥28,063,307.43, up from ¥17,970,637.73 in the previous period[21] - The company experienced a net cash outflow from investing activities of ¥10,689,308.29, compared to a smaller outflow of ¥137,850.81 in the previous period[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥558,071,291.47, a slight decrease of 0.48% from ¥560,740,396.04 at the end of the previous year[3] - Total current assets decreased from 440,493,573.77 CNY at the beginning of the year to 435,301,730.89 CNY at the end of the period, a decrease of approximately 0.43%[13] - Total liabilities decreased from 484,417,930.60 CNY to 476,737,488.40 CNY, a reduction of approximately 1.4%[15] - Total assets decreased from 560,740,396.04 CNY to 558,071,291.47 CNY, a decline of about 0.5%[15] Shareholder Information - Total number of common shareholders at the end of the reporting period is 65,524[9] - The largest shareholder, Weihai Weigao International Medical Investment Holding Co., Ltd., holds 17.50% of shares, totaling 53,825,800 shares[9] - Shareholders' equity attributable to the parent company increased by 6.62% to ¥81,826,057.33 from ¥76,746,376.03 at the end of the previous year[3] - The total equity attributable to shareholders of the parent company increased from 76,746,376.03 CNY to 81,826,057.33 CNY, an increase of approximately 6.7%[15] Operating Costs and Expenses - The company reported a decrease in total operating costs to ¥65,775,688.44 from ¥56,970,550.81, resulting in improved profitability[17] - Research and development expenses increased to ¥2,289,609.40 from ¥2,080,598.39, indicating a focus on innovation[17] - The company experienced a 142.32% increase in taxes and surcharges, amounting to ¥300,269.34 due to increased turnover taxes[6] Other Financial Metrics - The company reported a significant increase in other operating income, which rose by 945.81% to ¥130,478.24 compared to ¥12,476.28 in the previous year[6] - The company reported a 371.14% increase in receivables financing, reaching ¥11,414,601.47 compared to ¥2,422,782.93 in the previous year[6] - The company's retained earnings showed a slight improvement, moving from -1,037,947,558.95 CNY to -1,033,195,122.90 CNY[15]

证券代码：002248 证券简称：华东数控 威海华东数控股份有限公司 2020 年度业绩说明会投资者关系活动记录表 编号：2021-001 | --- | --- | --- | --- | --- | --- | --- | |------------------------|----------------------------------------------|------------------------------|-----------------------------------------------------------------------|-------|------------|--------| | | | | | | | | | 投资者关系活动类别 | □ 特定对象调研 | □ | 分析师会议 | | | | | | □ 媒体采访 | ☑ | 业绩说明会 | | | | | | □ 新闻发布会 | □ | 路演活动 | | | | | | | | | | | | | 参与单位名称及人员姓名 | □ 现场参观 □ 其他 通 过 全 景 网 " | | （请文字说明其他活动 ...

1 证券代码：002248 证券简称：华东数控 威海华东数控股份有限公司 投资者关系活动记录表 编号：2022-001 | --- | --- | --- | --- | --- | --- | |--------------------|-------------------------------------------------------|----------------------------------|-------------------------------------------------------------------------|--------------------|--------------------------------------------------------------------------------------------------------| | | | | | | | | 投资者关系活动类别 | □ 特定对象调研 □ 媒体采访 □ 新闻发布会 □ 现场参观 □ | 分析师会议 ☑ 业绩说明会 路演活动 | □ □ 其他（请文字说明其他活动 ...

1 证券代码：002248 证券简称：华东数控 公告编号：2022-042 威海华东数控股份有限公司 关于参加山东辖区上市公司 2022 年度投资者网上集体接待日 活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 为进一步加强与广大投资者的沟通交流，威海华东数控股份有限公司（简称 "公司"）将参加由山东证监局、山东上市公司协会等联合举办的"山东辖区上市公 司2022年度投资者网上集体接待日"活动，现将有关事项公告如下： 本次投资者网上集体接待日活动将通过全景路演平台举行，投资者可以登录 全景网"投资者关系互动平台"（http://ir.p5w.net/）参与本次投资者网上接待日活动。 网上互动交流时间为2022年11月16日（星期三）14:00-16:00。 届时公司董事会秘书刘璐、财务总监肖崔英将采用网络在线交流方式，与投 资者就公司治理、发展战略、经营状况等问题进行沟通，欢迎广大投资者积极参 与。 特此公告。 威海华东数控股份有限公司董事会 二〇二二年十一月十二日 ...

Financial Performance - The company's revenue for Q3 2022 was ¥61,470,841.25, a decrease of 18.05% compared to the same period last year[4] - Net profit attributable to shareholders was ¥3,302,229.19, an increase of 38.76% year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥1,438,808.86, up 1.49% from the previous year[4] - Total operating revenue for the current period was ¥197,464,606.30, a decrease of 15.36% from ¥233,377,086.86 in the previous period[20] - Net profit for the current period was ¥11,086,707.49, an increase of 43.5% compared to ¥7,712,539.75 in the previous period[20] - Basic earnings per share rose to ¥0.04 from ¥0.03, reflecting a 33.33% increase[20] Assets and Liabilities - Total assets at the end of the reporting period reached ¥589,032,681.09, reflecting an increase of 11.57% from the end of the previous year[4] - The total assets of the company reached ¥589,032,681.09, compared to ¥527,931,064.89 at the beginning of the year[18] - The company's total liabilities increased to ¥513,606,523.87 from ¥464,560,635.81 at the beginning of the year[18] - The company's inventory as of September 30, 2022, was ¥300,191,354.71, up from ¥247,926,491.03 at the beginning of the year[16] Cash Flow and Financing - Cash flow from operating activities showed a net outflow of ¥15,606,057.47, a significant decline of 169.72% year-to-date[4] - Cash flow from operating activities showed a net outflow of ¥15,606,057.47, compared to a net inflow of ¥22,382,652.38 in the previous period[24] - Cash and cash equivalents at the end of the period increased to ¥19,144,758.55 from ¥16,534,271.90, marking a net increase of ¥2,458,505.12[24] - The company received ¥60,000,000.00 in cash from borrowings, an increase from ¥40,000,000.00 in the previous period[24] - The company received government subsidies amounting to ¥998,125.29 during the reporting period, which is a significant increase compared to previous periods[5] - The company reported a significant increase in other income, which rose by 226.68% to ¥2,130,745.44 due to higher government subsidies received[8] - The company's cash and cash equivalents increased by 95.81% to ¥32,672,758.55 compared to the end of the previous year[8] Shareholder Information - The total number of common shareholders at the end of the reporting period is 56,239[10] - The largest shareholder, Weihai Weigao International Medical Investment Holding Co., Ltd., holds 17.50% of the shares, totaling 53,825,800 shares[10] Operational Strategy - The company reported a significant decline in new orders due to the pandemic, impacting its machine tool industry performance[11] - The company adopted a sales-driven production strategy to manage output and inventory effectively amid external challenges[11] Research and Development - Research and development expenses increased to ¥7,202,158.32, up from ¥6,896,219.15, indicating a focus on innovation[20] Cost Management - Total operating costs decreased to ¥186,403,184.96, down 17.6% from ¥226,222,871.59 in the previous period[20] - The company reported a decrease in sales expenses to ¥12,104,602.07 from ¥12,774,167.87, reflecting cost management efforts[20] Audit Information - The company has not conducted an audit for the third-quarter report[12]

Financial Performance - The company's operating revenue for the first half of 2022 was ¥135,993,765.05, a decrease of 14.13% compared to ¥158,369,811.79 in the same period last year[24]. - The net profit attributable to shareholders of the listed company increased by 17.64% to ¥7,996,155.92, up from ¥6,797,227.52 in the previous year[24]. - The net profit after deducting non-recurring gains and losses rose by 75.49% to ¥5,417,967.35, compared to ¥3,087,368.57 in the same period last year[24]. - The net cash flow from operating activities was negative at -¥1,031,518.83, a decline of 105.26% from ¥19,623,179.68 in the previous year[24]. - Total assets at the end of the reporting period were ¥580,874,687.38, reflecting a 10.03% increase from ¥527,931,064.89 at the end of the previous year[24]. - The net assets attributable to shareholders of the listed company increased by 13.59% to ¥72,396,564.15, compared to ¥63,735,493.02 at the end of the previous year[24]. - Basic earnings per share rose by 50.00% to ¥0.03, up from ¥0.02 in the same period last year[24]. - Diluted earnings per share also increased by 50.00% to ¥0.03, compared to ¥0.02 in the previous year[24]. - The weighted average return on equity decreased to 11.81%, down from 13.12% in the previous year, a decline of 1.31%[24]. - The company achieved operating revenue of 135.99 million yuan, a year-on-year decrease of 14.13%[37]. - Net profit attributable to shareholders increased by 17.64% to 7.9962 million yuan, while net profit excluding non-recurring gains and losses rose by 75.49% to 5.4180 million yuan[37]. - Total assets grew by 10.03% to 580.87 million yuan, and net assets attributable to shareholders increased by 13.59% to 72.3966 million yuan[37]. - The financial condition of the company has shown significant improvement, indicating a positive development phase in its operations[37]. - The company reported a total revenue of $1,250,000 for the first half of 2022, with a net loss of approximately $695,507.82[75]. Business Strategy and Operations - The company specializes in the research, production, and sales of CNC machine tools and key components, with no significant changes in its main business since establishment[34]. - The company adjusted its business strategy to continuously develop new products that meet market demand, enhancing marketing efforts and reducing product costs[38]. - The company is focused on expanding its market presence in emerging industries such as new energy vehicles and precision optical components[35]. - Future product development will continue to enhance the performance and efficiency of existing machine tools, targeting high-end manufacturing sectors[35]. - The company aims to leverage its technological advantages to capture a larger share of the domestic and international markets[35]. - The company has diversified its customer base across various industries, including railways, automotive, aerospace, and military, which helps mitigate market risks[76]. - The company faces significant competition in the machine tool industry, particularly in the CNC machine segment, where it competes with both domestic and foreign enterprises[78]. - The company has established partnerships with renowned foreign companies and domestic research institutions to enhance its technological capabilities and product development[79]. Research and Development - The company holds 171 patents, showcasing its commitment to innovation and maintaining a competitive edge in the high-tech CNC machine tool industry[39]. - The company has established several provincial-level R&D platforms, including a technology center and a postdoctoral research station, enhancing its research capabilities[40]. - The company’s R&D investment increased by 4.63% to ¥4,636,985.97, indicating a continued focus on innovation[47]. - The company emphasizes quality control and cost management from the design stage to enhance product price competitiveness[38]. - The company has developed new products and upgraded existing ones in response to the sustained demand in the machine tool market[38]. Cash Flow and Financial Management - The cash flow from operating activities showed a significant decline of 105.26%, resulting in a negative cash flow of ¥1,031,518.83 compared to a positive cash flow of ¥19,623,179.68 in the previous year[47]. - The net cash flow from investing activities was -2,074,100 CNY, a decrease of 3,507,630 CNY year-on-year, mainly due to reduced cash received from financial products[58]. - The net cash flow from financing activities was 18,406,800 CNY, an increase of 7,694,240 CNY year-on-year, primarily due to increased bank borrowings[61]. - Cash and cash equivalents at the end of the period amounted to 45,940,573.80 CNY, an increase of 175.32% from the beginning of the year, primarily due to bank loans received[55]. - The total cash inflow from operating activities decreased to 59,622,466.25 CNY in 2022 from 77,518,545.13 CNY in 2021, representing a decline of approximately 23%[145]. - Cash outflow from operating activities increased to 60,653,985.08 CNY in 2022, compared to 57,895,365.45 CNY in 2021, marking an increase of about 5%[145]. Environmental and Social Responsibility - The company emphasizes environmental responsibility by optimizing water usage and waste management, achieving compliance with environmental standards[89]. - The company has maintained a stable and high-quality workforce, which is crucial for its high-end CNC machine business development[81]. Shareholder Information - The company has not distributed cash dividends or bonus shares for the first half of 2022, nor has it increased capital through reserves[86]. - The total number of shares remained at 307,495,600, with no changes in the share structure[118]. - The largest shareholder, Weihai Weigao International Medical Investment Co., Ltd., holds 17.50% of shares, totaling 53,825,800 shares[121]. - The total equity attributable to the parent company at the end of the reporting period is CNY 63,370,429.08, unchanged from the previous period[152]. Legal and Compliance - The company's half-year financial report has not been audited[96]. - There were no significant litigation or arbitration matters during the reporting period[98]. - The company did not engage in any major related party transactions during the reporting period[100]. - There were no major contracts or guarantees during the reporting period[111]. - The company has assessed its ability to continue as a going concern and found no significant doubts regarding its ongoing viability[178].